SU‐GG‐T‐494: Clinically Derived Dose‐Response Relations for Rectum and Penile Bulb from Combined Photon and Proton Prostate Cancer Radiotherapy

Medicine and Dentistry

• Patient 100%
• Rectum 80%
• Proton 50%
• Pyrazinamide 40%
• Therapeutic Procedure 40%
• Analysis 20%
• Prostate 20%
• Side Effect 10%
• Adenocarcinoma 10%
• Maximum Likelihood Method 10%
• Sexual Dysfunction 10%
• Relative Biologic Effectiveness 10%
• Poly(methyl Methacrylate) 10%
• Radiotherapy Prostate Cancer 10%
• Proton Therapy 10%

Nursing and Health Professions

• Proton 50%
• Pyrazinamide 40%
• Parameters 40%
• Dose 40%
• Analysis 20%
• Clinical Outcome 10%
• Treatment Planning 10%
• Side Effect 10%
• Sexual Dysfunction 10%
• Adenocarcinoma 10%
• Procedures 10%
• Device Material 10%
• Poly(methyl Methacrylate) 10%
• Calculation 10%
• Maximum Likelihood Method 10%
• Proton Therapy 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Proton 50%
• Pyrazinamide 40%
• Side Effect 10%
• Adenocarcinoma 10%
• Sexual Dysfunction 10%
• Poly(methyl Methacrylate) 10%